Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
NGNE Neurogene
- 9.655
- -2.055-17.55%
Close Apr 1 16:00 ET
- 9.650
- -0.005-0.05%
Post 20:01 ET
144.14MMarket Cap-2.26P/E (TTM)
11.985High9.590Low560.62KVolume11.760Open11.710Pre Close5.79MTurnover10.11%Turnover RatioLossP/E (Static)14.93MShares74.49052wk High0.46P/B53.54MFloat Cap9.59052wk Low--Dividend TTM5.55MShs Float1115.000Historical High--Div YieldTTM20.45%Amplitude7.500Historical Low10.327Avg Price1Lot Size
Neurogene Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 58.45%312.41M | 58.45%312.41M | 205.06%138.99M | 160.64%153.91M | --169.53M | 140.37%197.16M | --197.16M | --45.56M | --59.05M | 16.27%82.02M |
| -Cash and cash equivalents | -7.84%136.59M | -7.84%136.59M | 46.24%66.63M | 88.03%111.03M | --150.14M | 80.70%148.21M | --148.21M | --45.56M | --59.05M | 16.27%82.02M |
| -Short-term investments | 259.20%175.82M | 259.20%175.82M | --72.36M | --42.87M | --19.39M | --48.95M | --48.95M | ---- | ---- | --0 |
| Receivables | 8.00%648K | 8.00%648K | 16.46%672K | 12.13%647K | --589K | -39.39%600K | --600K | --577K | --577K | 25.32%990K |
| -Other receivables | 8.00%648K | 8.00%648K | 16.46%672K | 12.13%647K | --589K | -39.39%600K | --600K | --577K | --577K | 25.32%990K |
| Prepaid assets | 26.27%1.89M | 26.27%1.89M | 18.80%2.38M | 52.16%3.07M | --2.77M | 38.78%1.5M | --1.5M | --2.01M | --2.02M | -43.65%1.08M |
| Other current assets | -10.41%981K | -10.41%981K | 62.27%1.6M | 106.89%1.53M | --1.25M | 73.81%1.1M | --1.1M | --986K | --740K | -11.39%630K |
| Total current assets | 57.69%315.92M | 57.69%315.92M | 192.38%143.65M | 155.12%159.15M | --174.14M | 136.49%200.35M | --200.35M | --49.13M | --62.38M | 14.55%84.72M |
| Non current assets | ||||||||||
| Net PPE | -11.74%18.49M | -11.74%18.49M | -11.36%19.35M | -14.26%19.54M | --20.13M | -14.64%20.95M | --20.95M | --21.82M | --22.79M | -10.84%24.55M |
| -Gross PPE | 2.42%29.66M | 2.42%29.66M | 2.47%29.73M | -0.10%29.13M | --28.92M | -1.20%28.96M | --28.96M | --29.02M | --29.16M | 0.73%29.31M |
| -Accumulated depreciation | -39.48%-11.17M | -39.48%-11.17M | -44.42%-10.39M | -50.53%-9.59M | ---8.79M | -68.01%-8.01M | ---8.01M | ---7.19M | ---6.37M | -203.44%-4.77M |
| Non current deferred assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.06M | --623K | ---- |
| Other non current assets | 3.30%1.31M | 3.30%1.31M | --1.13M | --1.13M | --1.08M | --1.27M | --1.27M | ---- | ---- | ---- |
| Total non current assets | -10.88%19.81M | -10.88%19.81M | -17.71%20.47M | -11.70%20.67M | --21.21M | -9.46%22.23M | --22.23M | --24.88M | --23.41M | -10.84%24.55M |
| Total assets | 50.84%335.73M | 50.84%335.73M | 121.75%164.12M | 109.60%179.82M | --195.35M | 103.70%222.57M | --222.57M | --74.01M | --85.79M | 7.66%109.27M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -48.54%1.34M | -48.54%1.34M | -21.09%1.68M | 12.75%1.72M | --1.52M | 315.36%2.6M | --2.6M | --2.13M | --1.53M | -88.90%625K |
| -accounts payable | -48.54%1.34M | -48.54%1.34M | -21.09%1.68M | 12.75%1.72M | --1.52M | 315.36%2.6M | --2.6M | --2.13M | --1.53M | -88.90%625K |
| Current accrued expenses | -53.21%5.05M | -53.21%5.05M | 147.73%6.48M | 113.80%4.49M | --4.73M | 499.22%10.79M | --10.79M | --2.62M | --2.1M | 34.93%1.8M |
| Current debt and capital lease obligation | 41.92%4.09M | 41.92%4.09M | 370.93%3.68M | 457.69%4.21M | --3.14M | 310.54%2.88M | --2.88M | --781K | --754K | 15.08%702K |
| -Current capital lease obligation | 41.92%4.09M | 41.92%4.09M | 370.93%3.68M | 457.69%4.21M | --3.14M | 310.54%2.88M | --2.88M | --781K | --754K | 15.08%702K |
| Other current liabilities | -53.60%342K | -53.60%342K | -57.48%523K | -30.22%508K | --1.25M | 341.32%737K | --737K | --1.23M | --728K | -37.45%167K |
| Current liabilities | -34.02%15.16M | -34.02%15.16M | 67.69%15.8M | 91.07%13.07M | --11.82M | 245.41%22.97M | --22.97M | --9.42M | --6.84M | -38.73%6.65M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -24.12%10.15M | -24.12%10.15M | 216.29%10.86M | 221.10%11.69M | --12.55M | 235.42%13.37M | --13.37M | --3.43M | --3.64M | -13.31%3.99M |
| -Long term capital lease obligation | -24.12%10.15M | -24.12%10.15M | 216.29%10.86M | 221.10%11.69M | --12.55M | 235.42%13.37M | --13.37M | --3.43M | --3.64M | -13.31%3.99M |
| Preferred securities outside stock equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --244.37M | --244.37M | 37.36%244.37M |
| Other non current liabilities | -74.88%51K | -74.88%51K | --51K | --51K | --203K | --203K | --203K | ---- | ---- | ---- |
| Total non current liabilities | -24.88%10.2M | -24.88%10.2M | -95.60%10.91M | -95.27%11.74M | --12.76M | -94.53%13.58M | --13.58M | --247.8M | --248.01M | 36.08%248.35M |
| Total liabilities | -30.63%25.36M | -30.63%25.36M | -89.62%26.71M | -90.27%24.81M | --24.57M | -85.67%36.55M | --36.55M | --257.22M | --254.85M | 31.88%255M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --1K | --1K | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --1K | --1K | --0 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Retained earnings | -40.15%-262.3M | -40.15%-262.3M | -28.09%-242.78M | -27.21%-222.57M | ---204.08M | -24.08%-187.15M | ---187.15M | ---189.54M | ---174.96M | -57.70%-150.84M |
| Paid-in capital | 53.46%572.67M | 53.46%572.67M | 5,909.14%380.2M | 6,293.18%377.58M | --374.85M | 7,220.09%373.18M | --373.18M | --6.33M | --5.91M | 35.15%5.1M |
| Total stockholders'equity | 66.85%310.38M | 66.85%310.38M | 175.00%137.41M | 191.70%155.01M | --170.78M | 227.64%186.02M | --186.02M | ---183.21M | ---169.05M | -58.63%-145.74M |
| Total equity | 66.85%310.38M | 66.85%310.38M | 175.00%137.41M | 191.70%155.01M | --170.78M | 227.64%186.02M | --186.02M | ---183.21M | ---169.05M | -58.63%-145.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
